Study protocol for a pilot randomized, double-blind, placebo-controlled trial to investigate the anti-inflammatory effects of Frondanol in adults with inflammatory bowel disease.

Ghelani, Hardik; Adrian, Thomas Edward; Ho, Samuel B; Akhras, Jamil; Azar, Aida J; Jan, Reem Kais

Ghelani, Hardik; Adrian, Thomas Edward; Ho, Samuel B; Akhras, Jamil; Azar, Aida J; Jan, Reem Kais.

Afiliación

Ghelani H; College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates.
Adrian TE; College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates.
Ho SB; College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates.
Akhras J; Gastroenterology Department, Mediclinic City Hospital, Dubai Healthcare City, Dubai, United Arab Emirates.
Azar AJ; College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates.
Jan RK; Gastroenterology Department, Mediclinic City Hospital, Dubai Healthcare City, Dubai, United Arab Emirates.

Contemp Clin Trials Commun ; 31: 101046, 2023 Feb.

Article en En | MEDLINE | ID: mdl-36544548

Palabras clave

Crohn's disease; Frondanol; Inflammatory bowel disease; Randomized controlled clinical trial; Sea cucumber; Ulcerative colitis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Idioma: En Revista: Contemp Clin Trials Commun Año: 2023 Tipo del documento: Article País de afiliación: Emiratos Árabes Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google